Date Range
Date Range
Date Range
Advanced Clinical Forms Scientific and Medical Affairs Division. Heading the Scientific and Medical Affairs Division is Dr. A highly respected leader in medical affairs and clinical services, Dr. We welcome an addition to our.
Monday, March 23, 2009.
Subscribe to California Biotech Law Blog. IPO Outlook for Biotech Remains Dreary in 2012. Biotech Industry Evaluates Anticipated Impact of Health Care Reform. California Biotech Law Blog Named to List of Top 50 Biotech Blogs. Carl Icahn Makes Move to Raid Genzyme Board.
Latest developments in Oncology market trends and intelligence. Monday, August 24, 2009. Resumption after an extended hiatus. Things have been really insanely busy on the work front over the last year, necessitating some radical prioritisation and thus I have only posted on Pharma Strategy Blog. Instead of here and Oncology Market Trends. Normal service will resume shortly. Monday, October 6, 2008. Zur Hausen discovered two high-risk types of the HPV vi.
Monday, April 6, 2009. End of an era for Pap smears? Read the surprising results. Of a large-scale cervical cancer trial conducted in India. The New York Times has the story here. 160;Could this DNA-based assay for HPV spell the end of annual Pap smears in developed countries, and of lower quality cervical cancer tests in resource-poor settings? Posted by Pavan Cheruvu. Sunday, April 5, 2009. FDA staffers vent to President.
Blogging for Clinical Research focus, the journal of The Institute of Clinical Research. Keith Rodgers on clinical project and programme management.
Is a top pharmaceutical eMarketing expert that consults in the fast-paced confluence of pharmaceutical marketing and Internet marketing. We understand both environments and appreciate the challenges associated with each. We bring to our clients 25 years of collaborative experience in the execution of medical strategy, medical education, KTL liaison, branded product management, and eMarketing communications. Visit our website for tools, products, and solutions you can use today.
Where experts go to learn about the FDA. Where experts go to learn about FDA. Where experts go to learn about FDA. CMS Finalizes New Medicaid Rebate Agreement.
Monday, August 24, 2009. Resumption after an extended hiatus. Things have been really insanely busy on the work front over the last year, necessitating some radical prioritisation and thus I have only posted on Pharma Strategy Blog. Instead of here and Oncology Market Trends. Monday, November 3, 2008.
Official Supplier of Harvard, MIT and more. InvivoChem, Drive Your Research! Highest Quality, Lowest Price! Experts of Small Molecule Inhibitors. Save Money, Save Time! Inhibitors, APIs and Chemical Intermediates. We manufacture and sell over 100 APIs from kilograms to metric tons scales.
Leadership is not about titles, positions or flowcharts. It is about one life influencing another. As a matter of fact, without the right role models and training, it is quite difficult. People work hard and find themselves promoted to leadership positions all the time. We may be good at what we were doing but pushed to a higher level, we start to drown. AND KEEP THE CLIENT ANYWAY.
If you change nothing, nothing. Wij geloven in een gezonde aanpak van psychische klachten, we leren je om jouw mogelijkheden te benutten en niet om je klachten centraal te stellen. Je komt weer in contact met je oorspronkelijke waarden. Welke waarden zijn echt belangrijk voor je? Voor welke richting durf je te kiezen? Wij helpen je er naar te handelen! Door deze positieve aanpak krijg je de ruimte om het leven te leiden zoals jij dat wilt. Veel mensen hebben last van bepaalde p.
KOL Researcher and KOL Profiler. Welcome to In Vivo Communications. In Vivo Communications was founded in response to a growing demand for quality medical education with strategic insight. With offices in Sydney and Singapore, we develop and implement highly effective communication programmes to meet the needs of our clients across the Asian and Australasian region.
Welcome to the web page of invivoContrast. We are a small company devoted to provide unique preclinical research contrast agents with reliable pharmaceutical quality. The MRI contrast agents Gadofluorine P. Have been developed and synthesized by Bayer Schering Pharma AG, and invivoContrast GmbH has manufactured a ready-to-use injection solution. Reliable quality and long term stability.